News
Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, ...
A new study shows that people Zepbound lost about 50% more weight than those using Wegovy. It was the first head-to-head ...
Gastrointestinal cancers often develop silently but knowing risk factors and warning signs can lead to earlier detection and ...
Ozempic, Wegovy and Mounjaro can still be expensive, but pharmacy-produced GLP-1 compounds are becoming much more affordable.
Turmeric and black pepper have a synergistic relationship. Learn how to use them together to increase turmeric’s anti-inflammatory benefits.
SAN DIEGO -- The oral full-spectrum microbiome drug EBX-102-02 was well tolerated with mostly mild gastrointestinal adverse ...
Self-help cognitive behavioral therapy for irritable bowel syndrome was successfully delivered via mobile application.
GLP-1 receptor agonists remain blockbuster drugs for weight management for people with overweight or obesity. Increasingly, ...
John Levine, M.D., a graft-versus-host-disease expert at the Icahn School of Medicine at Mount Sinai in New York, makes a ...
As weight loss medications, including Ozempic and WeGovy, have gained popularity across the U.S., they are not without side effects, some serious. According to a May 2024 CNN report, as many as 1 in 8 ...
In 2021, Sly, biochemistry professor Harry Brumer, and a group of other researchers at the UBC developed GlycoCage, a ...
Treatment with trofinetide is tied to improvements in caregiver-reported outcomes by 9 months in individuals with Rett ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results